Home About Us Surveys Reports News and Events Join Our Mailing List Contact Us
 


In the Spotlight

Latest Oncology News

This month's edition of Oncology and Business Review includes an article by Rhonda Greenapple, president of Reimbursement Intelligence, entitled Payer Reactions to Newly Presented Clinical Trial Results.

On July 8th, 2010, Rhonda Greenapple, President of Reimbursement Intelligence, was quoted in Pharmalot, from the publishers of PharmaLive.com, "What Insurers Say About The Provenge Vaccine."

Great New Medical Innovations
Don't Always Result in Blockbuster Products.

When making strategic investments and development decisions, it is imperative to consider access, pricing and reimbursement issues as part of your due diligence and business planning. Without an effective access and reimbursement strategy, even the best science can fail in the marketplace.

Reimbursement Intelligence provides an array of strategic services to get the managed care knowledge and assessment you need to turn high science into highly successful ventures.

Learn More >>